El-Laithy H.M.; Badawi A.; Abdelmalak N.S.; El-Sayyad N.
(Pharmaceutical Society of Japan, 2018)
Clopidogrel bisulphate (CB) is a first line antiplatelet drug for treatment of myocardial infarction and stroke. Yet, its efficacy is limited by its poor solubility in intestinal pH, its main site of absorption. The main ...